Search

Michael B. Pallay

Examiner (ID: 335, Phone: (571)270-3473 , Office: P/1617 )

Most Active Art Unit
1617
Art Unit(s)
1617
Total Applications
879
Issued Applications
427
Pending Applications
115
Abandoned Applications
374

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20023050 [patent_doc_number] => 20250161272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => Microsphere-Based Injectable Celecoxib Formulation [patent_app_type] => utility [patent_app_number] => 19/034843 [patent_app_country] => US [patent_app_date] => 2025-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13570 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19034843 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/034843
Microsphere-based injectable celecoxib formulation Jan 22, 2025 Issued
Array ( [id] => 20023050 [patent_doc_number] => 20250161272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => Microsphere-Based Injectable Celecoxib Formulation [patent_app_type] => utility [patent_app_number] => 19/034843 [patent_app_country] => US [patent_app_date] => 2025-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13570 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19034843 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/034843
Microsphere-based injectable celecoxib formulation Jan 22, 2025 Issued
Array ( [id] => 19768233 [patent_doc_number] => 20250049659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => ORAL COMPOSITIONS AND METHODS OF REDUCING ORAL MALODOR [patent_app_type] => utility [patent_app_number] => 18/930284 [patent_app_country] => US [patent_app_date] => 2024-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18930284 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/930284
ORAL COMPOSITIONS AND METHODS OF REDUCING ORAL MALODOR Oct 28, 2024 Pending
Array ( [id] => 19510408 [patent_doc_number] => 20240342094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => COMPARTMENTED PHARMACEUTICAL DOSAGE FORMS [patent_app_type] => utility [patent_app_number] => 18/740160 [patent_app_country] => US [patent_app_date] => 2024-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15274 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18740160 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/740160
COMPARTMENTED PHARMACEUTICAL DOSAGE FORMS Jun 10, 2024 Pending
Array ( [id] => 19691126 [patent_doc_number] => 20250009671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => COATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME [patent_app_type] => utility [patent_app_number] => 18/737814 [patent_app_country] => US [patent_app_date] => 2024-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18737814 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/737814
COATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME Jun 6, 2024 Pending
Array ( [id] => 19417259 [patent_doc_number] => 20240293382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE [patent_app_type] => utility [patent_app_number] => 18/662545 [patent_app_country] => US [patent_app_date] => 2024-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11733 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662545 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/662545
MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE May 12, 2024 Pending
Array ( [id] => 19417259 [patent_doc_number] => 20240293382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE [patent_app_type] => utility [patent_app_number] => 18/662545 [patent_app_country] => US [patent_app_date] => 2024-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11733 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662545 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/662545
MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE May 12, 2024 Pending
Array ( [id] => 19417259 [patent_doc_number] => 20240293382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE [patent_app_type] => utility [patent_app_number] => 18/662545 [patent_app_country] => US [patent_app_date] => 2024-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11733 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662545 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/662545
MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE May 12, 2024 Pending
Array ( [id] => 19613030 [patent_doc_number] => 20240398710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION [patent_app_type] => utility [patent_app_number] => 18/644608 [patent_app_country] => US [patent_app_date] => 2024-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18644608 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/644608
MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION Apr 23, 2024 Pending
Array ( [id] => 19613030 [patent_doc_number] => 20240398710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION [patent_app_type] => utility [patent_app_number] => 18/644608 [patent_app_country] => US [patent_app_date] => 2024-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18644608 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/644608
MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION Apr 23, 2024 Pending
Array ( [id] => 19359220 [patent_doc_number] => 20240261254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM [patent_app_type] => utility [patent_app_number] => 18/641369 [patent_app_country] => US [patent_app_date] => 2024-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20169 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641369 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/641369
DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM Apr 19, 2024 Pending
Array ( [id] => 19359220 [patent_doc_number] => 20240261254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM [patent_app_type] => utility [patent_app_number] => 18/641369 [patent_app_country] => US [patent_app_date] => 2024-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20169 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641369 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/641369
DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM Apr 19, 2024 Pending
Array ( [id] => 19331225 [patent_doc_number] => 20240245655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING SEPSIS [patent_app_type] => utility [patent_app_number] => 18/627293 [patent_app_country] => US [patent_app_date] => 2024-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18627293 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/627293
METHODS AND COMPOSITIONS FOR TREATING SEPSIS Apr 3, 2024 Abandoned
Array ( [id] => 19297828 [patent_doc_number] => 20240226394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => MULTI-LAYERED POLYMER FILM FOR SUSTAINED RELEASE OF AGENTS [patent_app_type] => utility [patent_app_number] => 18/609954 [patent_app_country] => US [patent_app_date] => 2024-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15988 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609954 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/609954
Multi-layered polymer film for sustained release of agents Mar 18, 2024 Issued
Array ( [id] => 19359315 [patent_doc_number] => 20240261349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => Pharmaceutical Complex for Radioprotection, Preparation Method, and Applications thereof [patent_app_type] => utility [patent_app_number] => 18/606877 [patent_app_country] => US [patent_app_date] => 2024-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5301 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606877 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/606877
Pharmaceutical Complex for Radioprotection, Preparation Method, and Applications thereof Mar 14, 2024 Abandoned
Array ( [id] => 19613349 [patent_doc_number] => 20240399029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => ADIPOSE TISSUE MATRICES [patent_app_type] => utility [patent_app_number] => 18/602676 [patent_app_country] => US [patent_app_date] => 2024-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5707 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602676 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/602676
ADIPOSE TISSUE MATRICES Mar 11, 2024 Abandoned
Array ( [id] => 19477271 [patent_doc_number] => 20240325313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI [patent_app_type] => utility [patent_app_number] => 18/592784 [patent_app_country] => US [patent_app_date] => 2024-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18601 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18592784 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/592784
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI Feb 29, 2024 Pending
Array ( [id] => 19232060 [patent_doc_number] => 20240189251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine [patent_app_type] => utility [patent_app_number] => 18/581460 [patent_app_country] => US [patent_app_date] => 2024-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581460 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/581460
Treatment of vomiting and nausea with minimum dose of olanzapine Feb 19, 2024 Issued
Array ( [id] => 19156061 [patent_doc_number] => 20240148768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => Method of Preventing and Treating COVID-19 Infection [patent_app_type] => utility [patent_app_number] => 18/411935 [patent_app_country] => US [patent_app_date] => 2024-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11267 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18411935 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/411935
Method of Preventing and Treating COVID-19 Infection Jan 11, 2024 Abandoned
Array ( [id] => 19156061 [patent_doc_number] => 20240148768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => Method of Preventing and Treating COVID-19 Infection [patent_app_type] => utility [patent_app_number] => 18/411935 [patent_app_country] => US [patent_app_date] => 2024-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11267 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18411935 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/411935
Method of Preventing and Treating COVID-19 Infection Jan 11, 2024 Abandoned
Menu